MedTrace Logo

A Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function

NCT07133477 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-08-21

No results posted yet for this study

Summary

The primary objective of the study is to determine the benefits of the food product EPAX Omega 3-9-11 on skin function.

Benefits (if any) will be determined by evaluating biophysical measurements of the face and inner forearm. Moreover, the study will determine the dosage effect of Omega-3-9-11 on these measurements.

Conditions

  • Skin Health

Interventions

DIETARY_SUPPLEMENT

Omega 3-9-11

Fish oil capsules containing a fish oil concentrate from North Atlantic fish species containing EPA / DHA / cetoleic acid and gondoic in controlled amounts.

DIETARY_SUPPLEMENT

Placebo

Corn oil capsules

Sponsors & Collaborators

  • Cutest Systems Ltd

    collaborator UNKNOWN

  • Epax Norway AS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2025-09-30
Completion
2025-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07133477 on ClinicalTrials.gov